UTHR – united therapeutics corporation (US:NASDAQ)

News

United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base [Yahoo! Finance]
United Therapeutics: Growing Company With Great Franchise In Pulmonary Diseases [Seeking Alpha]
United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com